The Technical Analyst
Misonix Inc [MSON]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Misonix Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $26.54
America/New_York / 31 des 1970 @ 19:00
| RATING 2022-02-09 |
|---|
| B+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/20 | 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 25.90 - 27.18 ( +/- 2.42%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-10-29 | Vizirgianakis Stavros G. | Sell | 2 136 478 | Common Stock |
| 2021-10-29 | Patton Thomas M | Sell | 104 500 | Common Stock |
| 2021-10-29 | Laviolette Paul A | Sell | 1 744 017 | Common Stock |
| 2021-10-29 | Dwyer Joseph P | Sell | 276 200 | Common Stock |
| 2021-06-30 | Waggoner Jonathan Jay | Buy | 15 000 | Stock Option |
| INSIDER POWER |
|---|
| 0.00 |
| Last 98 transactions |
| Buy: 1 378 801 | Sell: 4 339 021 |
Forecast:
01:40 - $26.52
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $26.54 (0.00% ) |
| Volume | 0.157 mill |
| Avg. Vol. | 0.0572 mill |
| % of Avg. Vol | 274.80 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MSON
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MSON
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Latest Press Releases
2021-10-04 19:15:00 - Press Release
Shareholder Alert: Weisslaw Llp Reminds Kra, Homb, Mson, And Vne Shareholders About Its Ongoing Investigations
New york, oct. 4, 2021 /prnewswire/ -- if you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: joshua rubin, esq. weisslaw llp305 broadway, 7th floor new york, ny 10007 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com kraton corporation (nyse: kra)weisslaw llp is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of kraton corporation (nyse: kra) in connection with the proposed acquisition of the company by dl chemical co., ltd.
2021-09-28 18:40:00 - Press Release
Shareholder Alert: Halper Sadeh Llp Investigates Hbmd, Acbi, Sbkk, Mson; Shareholders Are Encouraged To Contact The Firm
New york, sept. 28, 2021 /prnewswire/ -- halper sadeh llp, a global investor rights law firm, announces it is investigating the following companies: howard bancorp, inc. (nasdaq: hbmd) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale f.n.b.
2021-09-02 16:01:00 - Press Release
Misonix Reports Fourth Quarter And Fiscal Year 2021 Financial Results
Farmingdale, n.y., sept. 02, 2021 (globe newswire) -- misonix, inc. (nasdaq: mson) (“misonix” or the “company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2021 fourth quarter and full fiscal year ended june 30, 2021 as summarized below:
2021-07-31 10:42:00 - Press Release
Misonix Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Misonix, Inc. - Mson
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of misonix, inc. (nasdaqgs: mson) to bioventus inc. (nasdaq: bvs). under the terms of the proposed transaction, shareholders of misonix may elect to receive either (i) 1.6839 shares of bioventus class a common stock or (ii) $28.00 in cash, without interest, for each share of misonix that they own. ksf is seeking
2021-07-31 01:02:00 - Press Release
Shareholder Alert: Monteverde & Associates Pc Announces An Investigation Of Misonix, Inc. - Mson
New york, july 31, 2021 /prnewswire/ -- juan monteverde , founder and managing partner at monteverde & associates pc, a national securities firm rated top 50 in the 2018-2020 iss securities class action services report and headquartered at the empire state building in new york city, is investigating misonix, inc. ("mson" or the "company") (mson) relating to its proposed acquisition by bioventus, inc. mson shareholders will receive either $28.25 in cash or 1.6839 shares of bioventus per share they own. the investigation focuses on whether misonix, inc. and its board of directors violated securities laws and/or breached their fiduciary duties to the company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
Latest News
2021-10-04 19:15:00 - PRNewsWire
SHAREHOLDER ALERT: WeissLaw LLP Reminds KRA, HOMB, MSON, and VNE Shareholders About Its Ongoing Investigations
NEW YORK, Oct. 4, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP305 Broadway, 7th Floor New York, NY 10007 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com Kraton Corporation (NYSE: KRA)WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Kraton Corporation (NYSE: KRA) in connection with the proposed acquisition of the company by DL Chemical Co., Ltd.
2021-09-28 18:40:00 - PRNewsWire
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates HBMD, ACBI, SBKK, MSON; Shareholders are Encouraged to Contact the Firm
NEW YORK, Sept. 28, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Howard Bancorp, Inc. (NASDAQ: HBMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale F.N.B.
2021-09-02 16:01:00 - GlobeNewsWire
Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2021 fourth quarter and full fiscal year ended June 30, 2021 as summarized below:
2021-07-31 10:42:00 - Business Wire
MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. - MSON
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Misonix, Inc. (NasdaqGS: MSON) to Bioventus Inc. (Nasdaq: BVS). Under the terms of the proposed transaction, shareholders of Misonix may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix that they own. KSF is seeking
2021-07-31 01:02:00 - PRNewsWire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Misonix, Inc. - MSON
NEW YORK, July 31, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Misonix, Inc. ("MSON" or the "Company") (MSON) relating to its proposed acquisition by Bioventus, Inc. MSON shareholders will receive either $28.25 in cash or 1.6839 shares of Bioventus per share they own. The investigation focuses on whether Misonix, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
2021-07-30 15:53:00 - PRNewsWire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Misonix, Inc.
NEW YORK, July 30, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Misonix, Inc. ("Misonix" or the "Company") (NASDAQ: MSON) in connection with the proposed cash-and-stock acquisition of the Company by Bioventus Inc. ("Bioventus") (NASDAQ: BVS). Under the terms of the merger agreement, Misonix shareholders may elect to receive either (i) 1.6839 shares of Bioventus stock, representing implied per-share merger consideration of approximately $29.05 based upon Bioventus's July 29, 2021 closing price of $17.25, or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration based on an aggregate maximum cash amount payable by Bioventus equal to $10...
2021-07-30 07:01:52 - Benzinga
Bioventus Scoops Up Misonix In $518M Stock & Cash Deal; Raises FY21 Sales Outlook
Recently listed Bioventus Inc (NASDAQ: BVS) has agreed to acquire Misonix Inc (NASDAQ: MSON) for $518 million in a cash-and-stock transaction. Misonix stockholders may elect to receive either 1.6839 Bioventus shares or $28.00 in cash in the transaction.
2021-07-29 18:32:00 - Business Wire
Misonix Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Misonix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MSON
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Misonix, Inc. (NASDAQ: MSON) to Bioventus Inc. is fair to Misonix shareholders. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. Halper Sadeh encourages Misonix shareholders to click
2021-05-14 08:30:00 - GlobeNewsWire
Misonix Appoints Patrick J. Beyer to Board of Directors
Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Leadership and Financial Expertise to Board Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Leadership and Financial Expertise to Board
2021-05-10 13:30:00 - GlobeNewsWire
Misonix to Participate in Upcoming May and June Virtual Investor Conferences
FARMINGDALE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with Chief Financial Officer, Joe Dwyer, will be participating in the following upcoming virtual investor conferences in May and June: